Related Experiment Video

Updated: Aug 20, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000

Daniele Giardiello1,2,3, Maartje J Hooning4, Michael Hauptmann5

  • 1Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Breast Cancer Research : BCR
|November 24, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

344
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Related Experiment Videos

Last Updated: Aug 20, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

344
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

415
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
415

Articles linked to this work by shared authors, journal, and citation graph.

PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups.

medRxiv : the preprint server for health sciences·2026

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies.

Journal of the National Cancer Institute·2026

Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.

Hereditary cancer in clinical practice·2026

Germline ATRIP variants and the risk of ovarian cancer.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

The contribution of rare germline variants to the immune landscape of breast cancer.

Genome medicine·2026

Periostin and KIM-1 as Fibrosis-Related Markers Associated with CKD Stage in Children.

International journal of molecular sciences·2026

Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH).

Breast cancer research : BCR·2026

Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.

Breast cancer research : BCR·2026

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Breast cancer research : BCR·2026

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

Breast cancer research : BCR·2026

The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies.

Breast cancer research : BCR·2026

Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.

Breast cancer research : BCR·2026

Cell cycle-dependent translation-mediated turnover of the long noncoding RNA Malat1.

The Journal of cell biology·2026

Growth Patterns and Risk Stratification of Incidental Small Pure Ground-Glass Nodules across Independent Cohorts.

Radiology·2026

Generation of a New Immunodeficient Rat Model of Retinal Degeneration With LSL TdTomato Reporter and TdTomato-Pcp2 Expression.

Translational vision science & technology·2026

Multiplexed Profiling of Individual Extracellular Vesicles Reveals Lung Cancer-Associated Protein Signatures.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

The Tumor Microenvironment Score and Its Subsite-Specific Relevance in Colon Cancer.

The American journal of surgical pathology·2026

Plasma ACTH Precursors measured by Pro-opiomelanocortin (POMC) ELISA as a Predictor of Silent Corticotroph Adenomas.

The Journal of clinical endocrinology and metabolism·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us